A rare variant in EZH2 is associated with prostate cancer risk.
Raspin K, FitzGerald LM, Marthick JR, Field MA, Malley RC, Banks A, Donovan S, Thomson RJ, Foley GR, Stanford JL, Dickinson JL.
Raspin K, et al. Among authors: thomson rj.
Int J Cancer. 2021 Sep 1;149(5):1089-1099. doi: 10.1002/ijc.33584. Epub 2021 Apr 12.
Int J Cancer. 2021.
PMID: 33821477